Bronchogen and Cardiogen are each a short bioregulator peptide.
Bioregulators are taken in short courses and rest almost entirely on Russian research that has not been replicated elsewhere.
Same target, different schedules: Bronchogen courses; Cardiogen daily, in 10-20 day courses.
| Comparison | Bronchogen AEDL · Ala-Glu-Asp-Leu | Cardiogen Cardiogen · AEDR |
|---|---|---|
| How it works | How it works Bronchogen is four amino acids, marketed for lung and airway tissue. | How it works Cardiogen is 4 amino acids long, written AEDR. |
| What it is | A bioregulator for lung and airway health, with thin evidence. | A lab-made 4 amino acid peptide aimed at the heart muscle. |
| Status | Research only | Research only |
| Typical dose | — | — |
| How often | Courses | Daily, in 10-20 day courses |
| Stays active | Nothing published | Nothing published |
| Dose comes from | No established range | No established range |
| Cycled? | Courses of 10 to 20 days, repeated two or three times a year Community practice | Daily for 10 to 20 days, then a long break Community practice |
| What it does | ||
| Drug class | Bioregulator peptide | Bioregulator (AEDR) |
| Used for | A bioregulator aimed at lung and airway health, taken in short courses. | Marketed for heart muscle and blood vessels as they age. Taken in short courses. |
| Receptors hit | — | — |
| Numbers | ||
| Full dose line | Varies (course-based) | Research only |
| Why that cycle | The course structure is how the Khavinson protocols specify these and how they are sold. No trial has compared course dosing against continuous use, or established how long the gap between courses should be. | The whole family is used in short courses repeated a few times a year. That pattern comes from Russian practice, not from a trial comparing it against anything else. |
| Weight / effect | Not measured in a trial | Not measured in a trial |
| Chain length | 4 residues | 4 residues |
| Common vial | 10 mg | 10 mg |
| Before you start | ||
| Route | Under the skin, or by mouth | Under the skin, or by mouth |
| Do not use if | Pregnancy or breastfeeding Any prescription medicine you take regularly, without checking for interactions first Anyone who wants established safety data, because none exists for this compound in humans | Pregnancy or breastfeeding Active cancer, as a precaution given the claimed effect on gene activity Known allergy to it |
What separates them
Proof behind the dose. Every dose here comes from community practice. Not one is backed by a published human study, which is worth knowing before you read the numbers as if they were equivalent.
What doesn't differ: They are both taken the same way (under the skin, or by mouth). Neither has a measured effect size from a published trial, so there is no number to rank them on.
What people actually report
Bronchogen
- Little human evidence.
- Spreading hives, swelling of the face or throat, or trouble breathing, which can happen with any injection and is a medical emergency
- Redness, heat, or pus at the injection site, which can signal infection
Cardiogen
- Little human evidence.
- Signs of an allergic reaction such as face or throat swelling, hives, or trouble breathing
- Redness, heat, or pus where it was injected
Side effects are what users and trials report most often, not a complete list. Anything sudden, spreading, or breathing-related is an emergency regardless of which compound caused it.
People also compare
This comparison does not cover cost, long-term safety, or how you personally will respond. Effect figures come from separate trials in different populations and are not always directly comparable to each other. Nothing here is medical advice or a recommendation to use any of these. Talk to a clinician about your own situation.